Profile data is unavailable for this security.
About the company
The Simply Good Foods Company is a consumer-packaged food and beverage company. The product portfolio the Company develops, markets, and sells consists primarily of protein bars, ready-to-drink (RTD) shakes, sweet and salty snacks, and confectionery products marketed under the Atkins, and Quest brand names. The Company's nutritious snacking platform consists of brands that specialize in providing products for consumers that follow certain nutritional philosophies and health-and-wellness trends. Atkins brand specializes in providing products for consumers following a low-carb lifestyle or seeking to lose weight, and Quest brand for consumers seeking a variety of protein-rich foods and beverages. Atkins brand products consist of protein bars, RTD shakes, confections, cookies, and chips. It distributes its products in retail channels, primarily in North America, including grocery, club, and mass merchandise, as well as through e-commerce, convenience, specialty, and other channels.
- Revenue in USD (TTM)1.27bn
- Net income in USD140.76m
- Incorporated2017
- Employees271.00
- LocationSimply Good Foods Co1225 17th St Ste 1000DENVER 80202-5599United StatesUSA
- Phone+1 (303) 633-2840
- Fax+1 (302) 636-5454
- Websitehttps://www.thesimplygoodfoodscompany.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xenon Pharmaceuticals Inc | 0.00 | -182.39m | 3.02bn | 251.00 | -- | 3.26 | -- | -- | -2.73 | -2.73 | 0.00 | 12.31 | 0.00 | -- | -- | 0.00 | -21.22 | -20.71 | -21.86 | -21.81 | -- | -- | -- | -683.58 | -- | -- | 0.00 | -- | -100.00 | -- | -45.99 | -- | 61.77 | -- |
10X Genomics Inc | 618.73m | -255.10m | 3.21bn | 1.26k | -- | 4.32 | -- | 5.18 | -2.18 | -2.18 | 5.28 | 6.22 | 0.6206 | 2.70 | 5.65 | 491,443.20 | -25.59 | -25.52 | -29.39 | -29.05 | 66.15 | 75.88 | -41.23 | -48.53 | 4.11 | -- | 0.00 | -- | 19.81 | 33.43 | -53.67 | -- | 49.15 | -- |
Iovance Biotherapeutics Inc | 1.19m | -444.04m | 3.22bn | 557.00 | -- | 5.06 | -- | 2,710.85 | -1.89 | -1.89 | 0.0051 | 2.28 | 0.0017 | -- | -- | 2,134.65 | -61.49 | -51.47 | -71.47 | -57.56 | -804.54 | -- | -37,345.42 | -137,873.80 | 2.70 | -- | 0.0017 | -- | -- | -- | -12.16 | -- | 79.44 | -- |
Fortrea Holdings Inc | 3.11bn | -3.40m | 3.25bn | 18.00k | -- | 1.86 | 34.93 | 1.04 | -0.0379 | -0.0379 | 35.03 | 19.58 | -- | -- | -- | 172,722.20 | -- | -- | -- | -- | 16.74 | -- | -0.1094 | -- | -- | 1.27 | 0.478 | -- | 0.4167 | -- | -101.76 | -- | -- | -- |
SpringWorks Therapeutics Inc | 5.45m | -325.10m | 3.27bn | 305.00 | -- | 5.19 | -- | 600.96 | -5.14 | -5.14 | 0.0862 | 8.52 | 0.008 | -- | -- | 17,859.02 | -47.95 | -36.97 | -53.00 | -39.49 | 92.25 | -- | -5,968.50 | -2,176.46 | 6.37 | -- | 0.00 | -- | -- | -- | -17.19 | -- | 90.68 | -- |
Crinetics Pharmaceuticals Inc | 4.01m | -214.53m | 3.30bn | 290.00 | -- | 5.35 | -- | 821.24 | -3.70 | -3.70 | 0.0691 | 7.91 | 0.0081 | -- | 0.7048 | 13,837.93 | -42.39 | -42.53 | -45.71 | -45.36 | -- | -- | -5,216.32 | -5,446.39 | -- | -- | 0.00 | -- | -15.28 | 10.57 | -30.88 | -- | 34.65 | -- |
Axsome Therapeutics Inc | 270.60m | -239.24m | 3.39bn | 545.00 | -- | 17.73 | -- | 12.52 | -5.20 | -5.20 | 5.96 | 4.03 | 0.5885 | 2.68 | 4.08 | 496,513.80 | -52.02 | -64.55 | -69.92 | -82.23 | 90.37 | -- | -88.41 | -227.05 | 3.52 | -35.93 | 0.4825 | -- | 440.80 | -- | -27.84 | -- | 77.86 | -- |
Biohaven Ltd | 0.00 | -408.17m | 3.40bn | 239.00 | -- | 7.30 | -- | -- | -5.67 | -5.67 | 0.00 | 5.28 | 0.00 | -- | -- | 0.00 | -69.48 | -- | -79.29 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 28.43 | -- | -- | -- |
Immunitybio Inc | 622.00k | -583.20m | 3.44bn | 628.00 | -- | -- | -- | 5,536.81 | -1.13 | -1.13 | 0.0012 | -0.875 | 0.0014 | -- | 0.246 | 990.45 | -134.71 | -112.76 | -377.77 | -316.07 | -- | -- | -93,866.88 | -37,700.74 | -- | -2.08 | 3.32 | -- | 159.17 | 67.62 | -40.00 | -- | 18.48 | -- |
Simply Good Foods Co | 1.27bn | 140.76m | 3.46bn | 271.00 | 24.86 | 2.10 | 21.38 | 2.73 | 1.39 | 1.39 | 12.53 | 16.48 | 0.5977 | 6.91 | 8.56 | 4,671,908.00 | 6.65 | 3.66 | 6.95 | 3.83 | 37.26 | 38.90 | 11.12 | 6.80 | 3.09 | 9.26 | 0.1261 | 0.00 | 6.33 | 23.56 | 23.03 | 13.65 | 47.09 | -- |
Ultragenyx Pharmaceutical Inc | 434.25m | -606.64m | 3.61bn | 1.28k | -- | 13.11 | -- | 8.31 | -8.33 | -8.33 | 5.91 | 3.35 | 0.286 | 1.49 | 7.63 | 340,320.50 | -39.96 | -33.35 | -48.63 | -38.30 | 89.59 | 93.13 | -139.70 | -154.71 | 2.49 | -- | 0.00 | -- | 19.52 | 53.18 | 14.25 | -- | 62.91 | -- |
Alvotech SA | 93.38m | -551.73m | 3.64bn | 999.00 | -- | -- | -- | 39.00 | -2.40 | -2.40 | 0.4109 | -3.49 | 0.105 | 2.20 | 1.39 | 93,475.48 | -62.04 | -- | -81.72 | -- | -72.26 | -- | -590.83 | -- | 0.4614 | -1.29 | 7.52 | -- | 9.84 | -- | -7.43 | -- | -- | -- |
Insmed Inc | 305.21m | -749.57m | 3.70bn | 912.00 | -- | -- | -- | 12.13 | -5.35 | -5.35 | 2.17 | -2.24 | 0.2044 | 0.8562 | 8.61 | 334,657.90 | -50.20 | -40.96 | -58.32 | -46.88 | 78.52 | 77.99 | -245.59 | -212.92 | 3.75 | -17.21 | 1.39 | -- | 24.39 | 98.78 | -55.66 | -- | -2.15 | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Dec 2023 | 13.06m | 13.08% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 10.66m | 10.68% |
Capital Research & Management Co. (World Investors)as of 31 Dec 2023 | 6.16m | 6.17% |
T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 3.41m | 3.42% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 3.39m | 3.40% |
Champlain Investment Partners LLCas of 31 Dec 2023 | 3.08m | 3.09% |
Dimensional Fund Advisors LPas of 31 Dec 2023 | 2.89m | 2.90% |
Silvercrest Asset Management Group LLCas of 31 Dec 2023 | 2.79m | 2.79% |
Neuberger Berman Investment Advisers LLCas of 31 Dec 2023 | 2.42m | 2.43% |
Fuller & Thaler Asset Management, Inc.as of 31 Dec 2023 | 2.01m | 2.02% |